Skip to main content

RETACRIT

NDC 59353-120 · Vifor (International) Inc.

Generic nameepoetin alfa-epbx
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS, SUBCUTANEOUS
Active ingredient(s)EPOETIN
Strength20000 [iU]/mL
Pharmacologic classErythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]
Marketing categoryBLA

Packages

59353-120-10 — 10 VIAL, MULTI-DOSE in 1 CARTON (59353-120-10) / 1 mL in 1 VIAL, MULTI-DOSE (59353-120-01)

Billed under HCPCS

Q5105 — Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units Medicare Part B payment limit (ASP + 6%): $0.80

Q5106 — Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units Medicare Part B payment limit (ASP + 6%): $7.97

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0069-1311 — epoetin alfa-epbx, 0069-1318 — epoetin alfa-epbx, 55513-126 — epoetin alfa, 55513-144 — epoetin alfa, 55513-148 — epoetin alfa, 55513-267 — epoetin alfa, 55513-283 — epoetin alfa, 55513-478 — epoetin alfa, 59353-002 — epoetin alfa-epbx, 59353-003 — epoetin alfa-epbx, 59353-004 — epoetin alfa-epbx, 59353-010 — epoetin alfa-epbx, 59353-220 — epoetin alfa-epbx, 59676-302 — Erythropoietin, 59676-303 — Erythropoietin, 59676-304 — Erythropoietin, 59676-310 — Erythropoietin, 59676-312 — Erythropoietin, 59676-320 — Erythropoietin, 59676-340 — Erythropoietin, +5 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels